These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ATN status in amnestic and non-amnestic Alzheimer's disease and frontotemporal lobar degeneration. Cousins KAQ; Irwin DJ; Wolk DA; Lee EB; Shaw LMJ; Trojanowski JQ; Da Re F; Gibbons GS; Grossman M; Phillips JS Brain; 2020 Jul; 143(7):2295-2311. PubMed ID: 32666090 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Biomarkers for the Diagnosis and Classification of Alzheimer's Disease Spectrum. Lee J; Jang H; Kang SH; Kim J; Kim JS; Kim JP; Kim HJ; Seo SW; Na DL J Korean Med Sci; 2020 Nov; 35(44):e361. PubMed ID: 33200589 [TBL] [Abstract][Full Text] [Related]
4. Moving fluid biomarkers for Alzheimer's disease from research tools to routine clinical diagnostics. Zetterberg H; Blennow K Mol Neurodegener; 2021 Feb; 16(1):10. PubMed ID: 33608044 [TBL] [Abstract][Full Text] [Related]
6. Biomarkers for Alzheimer's disease: current status and prospects for the future. Blennow K; Zetterberg H J Intern Med; 2018 Dec; 284(6):643-663. PubMed ID: 30051512 [TBL] [Abstract][Full Text] [Related]
11. Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers. Bridel C; Somers C; Sieben A; Rozemuller A; Niemantsverdriet E; Struyfs H; Vermeiren Y; Van Broeckhoven C; De Deyn PP; Bjerke M; Nagels G; Teunissen CE; Engelborghs S Brain; 2022 Nov; 145(11):4056-4064. PubMed ID: 35026840 [TBL] [Abstract][Full Text] [Related]
12. Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's disease. Lim B; Fowler C; Li QX; Rowe C; Dhiman K; Gupta VB; Masters CL; Doecke JD; Martins RN; Collins S; Diamandis EP Neurosci Lett; 2020 Jul; 731():135078. PubMed ID: 32450185 [TBL] [Abstract][Full Text] [Related]
13. Correlation between Cerebrospinal Fluid Core Alzheimer's Disease Biomarkers and β-Amyloid PET in Chinese Dementia Population. Xie Q; Ni M; Gao F; Dai LB; Lv XY; Zhang YF; Shi Q; Zhu XX; Xie JK; Shen Y; Wang SC ACS Chem Neurosci; 2022 May; 13(10):1558-1565. PubMed ID: 35476397 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid biomarkers for Alzheimer's disease: current limitations and recent developments. Zetterberg H Curr Opin Psychiatry; 2015 Sep; 28(5):402-9. PubMed ID: 26147615 [TBL] [Abstract][Full Text] [Related]
15. Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease. Alawode DOT; Heslegrave AJ; Ashton NJ; Karikari TK; Simrén J; Montoliu-Gaya L; Pannee J; O Connor A; Weston PSJ; Lantero-Rodriguez J; Keshavan A; Snellman A; Gobom J; Paterson RW; Schott JM; Blennow K; Fox NC; Zetterberg H J Intern Med; 2021 Sep; 290(3):583-601. PubMed ID: 34021943 [TBL] [Abstract][Full Text] [Related]
16. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model. Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W; J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Two Analytical Platforms in Cerebrospinal Fluid Biomarkers for the Classification of Alzheimer's Disease Spectrum with Amyloid PET Imaging. Lim HJ; Park JE; Kim BC; Choi SM; Song MK; Cho SH; Seo HJ; Kim J; Song HC; Choi KY; Lee JJ; Kim HW; Ha JM; Song WK; Park SG; Lee JS; Lee KH J Alzheimers Dis; 2020; 75(3):949-958. PubMed ID: 32390627 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease. Palmqvist S; Insel PS; Stomrud E; Janelidze S; Zetterberg H; Brix B; Eichenlaub U; Dage JL; Chai X; Blennow K; Mattsson N; Hansson O EMBO Mol Med; 2019 Dec; 11(12):e11170. PubMed ID: 31709776 [TBL] [Abstract][Full Text] [Related]
19. Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers. Ramos de Matos M; Ferreira C; Herukka SK; Soininen H; Janeiro A; Santana I; Baldeiras I; Almeida MR; Lleó A; Dols-Icardo O; Alcolea D; Benussi L; Binetti G; Paterlini A; Ghidoni R; Nacmias B; Meulenbroek O; van Waalwijk van Doorn LJC; Kuiperi HBJ; Hausner L; Waldemar G; Simonsen AH; Tsolaki M; Gkatzima O; Resende de Oliveira C; Verbeek MM; Clarimon J; Hiltunen M; de Mendonça A; Martins M J Alzheimers Dis; 2018; 66(2):639-652. PubMed ID: 30320580 [TBL] [Abstract][Full Text] [Related]